Animal-Assisted Therapy in the Residential Treatment of Schizophrenia and Addictions
1 other identifier
interventional
160
0 countries
N/A
Brief Summary
Animal-assisted therapy (AAT) is a complementary intervention of therapy that has shown positive results in the treatment of various pathologies. This study assesses the viability of the implementation and the efectiveness of an AAT program in patients diagnosed with substance abuse disorder and associated mental disorders (dual pathology).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2019
CompletedFirst Submitted
Initial submission to the registry
October 20, 2021
CompletedFirst Posted
Study publicly available on registry
November 2, 2021
CompletedNovember 2, 2021
October 1, 2021
3.5 years
October 20, 2021
October 30, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
The Life Skills Profile questionnaire (LSP)
This questionnaire evaluates aspects of functioning that affect daily activities and the adaptation of people with mental illnesses in the community. It contains 39 items that are grouped into self-care, social-interpersonal behaviour, communication-social contact, non-personal social behaviour and autonomous life
Change from Life Skills at 3-6-9 months (12 minutes)
Barrat impulsiveness scale (BIS-11)
This instrument is composed of 30 items distributed into three sub-scales: nonplanning, motor and attentional. The total impulsiveness score was also obtained.
Change from impulsiveness at 3-6-9 months (12 minutes)
Calgary Depresión Scale for Schizophrenia (CDSS)
El cuestionario es un intrumento estructurado, adminisitrado por un clínico de forma heteroaplicada para población adulta, con un tiempo aproximado de administración de entre 10 y 30 minutos, y aborada el área terapéutica relativa a la sintomatología de los trastornos depresivos.
Change from Depresión at 3-6-9 months (12 minutes)
Rosenberg Self-Esteem Scale
The questionnaire consists of 10 statements of the feelings that the person has about himself. Five of the statements are addressed positively (items 1, 2, 4, 6 and 7) and 5 negatively (items 3, 5, 8, 9 and 10).
Change from self.-esteem at 3-6-9 months (12 minutes)
Positive and negative symptom scale (PANSS)
It is a semi-structured and hetero-applied questionnaire for the adult population. The application time is between 30-60 minutes and evaluates the positive and negative symptoms of schizophrenia and other psychotic disorders.
Change from Positive and negative symptom at 3-6-9 months (12 minutes)
Study Arms (2)
Experimental group (EG)
EXPERIMENTALControl group
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Meeting DSM-5 criteria for substance abuse disorder and the presence of schizophrenia
- Voluntary participant in the study and having signed the informed consent
You may not qualify if:
- Patients whose functioning could be altered by factors not specifically related to addictive pathology or mental disorder (severe cognitive impairment, intellectual deficiency or language barrier)
- Animal-specific phobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Sponsor-investigator
Study Record Dates
First Submitted
October 20, 2021
First Posted
November 2, 2021
Study Start
November 3, 2015
Primary Completion
May 20, 2019
Study Completion
September 10, 2019
Last Updated
November 2, 2021
Record last verified: 2021-10